0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight tinea versicolor cutaneous mycoses global api manufacturers marketed phase iii 0.Your search for "" gave back 1533061 results.
20s Proteasome - Drugs in Development, 2021 Summary 20s Proteasome pipeline Target constitutes close to 9 molecules. Out of which approximately 6...
Catalog:
Global Markets Direct
September 2021
Price: USD 3,500.00
Tyrosine Protein Kinase ITK/TSK - Pipeline Review, H1 2020 Summary Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA,...
Catalog:
Global Markets Direct
July 2022
Price: USD 3,500.00
Tyrosine Protein Kinase ITKTSK - Pipeline Review, H2 2019 Summary Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
20s Proteasome - Pipeline Review, H2 2019 Summary 20s Proteasome - 20S proteasome is the catalytic core of the 26S proteasome, the central protease...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Asia Pacific small molecule contract development and manufacturing organization (CDMO) market will grow by 8.3% annually with a total addressable...
Grace Market Data
December 2022
Price: USD 3,000.00
Europe small molecule contract development and manufacturing organization (CDMO) market was valued at $ 17,340.6 million in 2021 and will grow by 6.2...
Grace Market Data
December 2022
Price: USD 3,000.00
North America small molecule contract development and manufacturing organization (CDMO) market is projected to grow by 5.3% annually in the forecast...
Grace Market Data
December 2022
Price: USD 3,000.00
North America pharmaceutical CDMO market is expected to grow by 6.0% annually in the forecast period and reach $101.1 billion by 2030 driven by...
Catalog:
Grace Market Data
December 2020
Price: USD 3,300.00
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline Review, H1 2018 Summary Histone Deacetylase 4 (Histone Deacetylase A...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Pipeline Review, H1 2018 Summary Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
20s Proteasome - Pipeline Review, H2 2020 Summary According to the recently published report '20s Proteasome - Pipeline Review, H2 2020';...
Catalog:
Global Markets Direct
November 2020
Price: USD 3,500.00
Asia Pacific pharmaceutical CDMO market will grow by 8.3% annually with a total addressable market cap of $725.2 billion over 2020-2030 owing to the...
Catalog:
Grace Market Data
December 2020
Price: USD 3,300.00
Europe pharmaceutical CDMO market accounted for $37.17 billion in 2019 and will grow by 6.7% annually over 2020-2030 owing to the rising demand for...
Catalog:
Grace Market Data
December 2020
Price: USD 3,300.00
Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Drugs In Development, 2021 Summary Histone Deacetylase 3 (SMAP45 or RPD3 2 or...
Catalog:
Global Markets Direct
August 2021
Price: USD 3,500.00
